Standard
Engineering of an Inhalable DDA/TDB Liposomal Adjuvant : A Quality-by-Design Approach Towards Optimization of the Spray Drying Process. / Ingvarsson, Pall Thor; Yang, Mingshi; Mulvad, Helle; Nielsen, Hanne Mørck; Rantanen, Jukka; Foged, Camilla.
In:
Pharmaceutical Research, Vol. 30, No. 11, 22.06.2013, p. 2772-2784.
Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
Ingvarsson, PT
, Yang, M, Mulvad, H
, Nielsen, HM, Rantanen, J & Foged, C 2013, '
Engineering of an Inhalable DDA/TDB Liposomal Adjuvant: A Quality-by-Design Approach Towards Optimization of the Spray Drying Process',
Pharmaceutical Research, vol. 30, no. 11, pp. 2772-2784.
https://doi.org/10.1007/s11095-013-1096-2APA
Ingvarsson, P. T.
, Yang, M., Mulvad, H.
, Nielsen, H. M., Rantanen, J., & Foged, C. (2013).
Engineering of an Inhalable DDA/TDB Liposomal Adjuvant: A Quality-by-Design Approach Towards Optimization of the Spray Drying Process.
Pharmaceutical Research,
30(11), 2772-2784.
https://doi.org/10.1007/s11095-013-1096-2Vancouver
Ingvarsson PT
, Yang M, Mulvad H
, Nielsen HM, Rantanen J, Foged C.
Engineering of an Inhalable DDA/TDB Liposomal Adjuvant: A Quality-by-Design Approach Towards Optimization of the Spray Drying Process.
Pharmaceutical Research. 2013 Jun 22;30(11):2772-2784.
https://doi.org/10.1007/s11095-013-1096-2Author
Ingvarsson, Pall Thor ; Yang, Mingshi ; Mulvad, Helle ; Nielsen, Hanne Mørck ; Rantanen, Jukka ; Foged, Camilla. / Engineering of an Inhalable DDA/TDB Liposomal Adjuvant : A Quality-by-Design Approach Towards Optimization of the Spray Drying Process. In: Pharmaceutical Research. 2013 ; Vol. 30, No. 11. pp. 2772-2784.
Bibtex
@article{3c08a6bb8e914161b0532e9ecf39bf37,
title = "Engineering of an Inhalable DDA/TDB Liposomal Adjuvant: A Quality-by-Design Approach Towards Optimization of the Spray Drying Process",
abstract = "The purpose of this study was to identify and optimize spray drying parameters of importance for the design of an inhalable powder formulation of a cationic liposomal adjuvant composed of dimethyldioctadecylammonium (DDA) bromide and trehalose-6,6'-dibehenate (TDB).",
author = "Ingvarsson, {Pall Thor} and Mingshi Yang and Helle Mulvad and Nielsen, {Hanne M{\o}rck} and Jukka Rantanen and Camilla Foged",
year = "2013",
month = jun,
day = "22",
doi = "10.1007/s11095-013-1096-2",
language = "English",
volume = "30",
pages = "2772--2784",
journal = "Pharmaceutical Research",
issn = "0724-8741",
publisher = "Springer",
number = "11",
}
RIS
TY - JOUR
T1 - Engineering of an Inhalable DDA/TDB Liposomal Adjuvant
T2 - A Quality-by-Design Approach Towards Optimization of the Spray Drying Process
AU - Ingvarsson, Pall Thor
AU - Yang, Mingshi
AU - Mulvad, Helle
AU - Nielsen, Hanne Mørck
AU - Rantanen, Jukka
AU - Foged, Camilla
PY - 2013/6/22
Y1 - 2013/6/22
N2 - The purpose of this study was to identify and optimize spray drying parameters of importance for the design of an inhalable powder formulation of a cationic liposomal adjuvant composed of dimethyldioctadecylammonium (DDA) bromide and trehalose-6,6'-dibehenate (TDB).
AB - The purpose of this study was to identify and optimize spray drying parameters of importance for the design of an inhalable powder formulation of a cationic liposomal adjuvant composed of dimethyldioctadecylammonium (DDA) bromide and trehalose-6,6'-dibehenate (TDB).
U2 - 10.1007/s11095-013-1096-2
DO - 10.1007/s11095-013-1096-2
M3 - Journal article
C2 - 23794038
VL - 30
SP - 2772
EP - 2784
JO - Pharmaceutical Research
JF - Pharmaceutical Research
SN - 0724-8741
IS - 11
ER -
